Algunos mdicos usan BPC-157 solo durante la ventana de titulacin de GLP-1 (los primeros 3 a 4 meses cuando los efectos secundarios GI son ms altos), luego reducen gradualmente una vez que la dosis de mantenimiento est estable y bien tolerada
Among available RCTs, only hematologic outcomes were assessed: no evidence exists to confirm the assumption that hematologic outcomes gained with adjuvant therapy share the same risk-benefit profile as those gained with ESA and iron therapy alone
Martinez C, Gonzalez-Castro A, Vicario M, Santos J
Thiol/disulfide homeostasis as a marker of oxidative stress in rosacea: a controlled spectrophotometric study Cutan Ocul Toxicol
Many older people could turn out to be outright deficient (group X) independent of the criteria used (Fig 4)
Clinical Evidence for Effects on Skin The topical peptide review by Schagen summarized placebo-controlled and comparative studies in which Cu-GHK products were associated with collagen production and visible skin-aging measures [2]